title: Breast Cancer-Associated Fibroblasts: Where We Are and Where We Need to Go.
abstract: Cancers are heterogeneous tissues comprised of multiple components, including tumor cells and microenvironment cells. The tumor microenvironment has a critical role in tumor progression. The tumor microenvironment is comprised of various cell types, including fibroblasts, macrophages and immune cells, as well as extracellular matrix and various cytokines and growth factors. Fibroblasts are the predominant cell type in the tumor microenvironment. However, neither the derivation of tissue-specific cancer-associated fibroblasts nor markers of tissue-specific cancer-associated fibroblasts are well defined. Despite these uncertainties it is increasingly apparent that cancer-associated fibroblasts have a crucial role in tumor progression. In breast cancer, there is evolving evidence showing that breast cancer-associated fibroblasts are actively involved in breast cancer initiation, proliferation, invasion and metastasis. Breast cancer-associated fibroblasts also play a critical role in metabolic reprogramming of the tumor microenvironment and therapy resistance. This review summarizes the current understanding of breast cancer-associated fibroblasts.
authors.affiliation: Molecular Oncology Research Institute and Department of Medicine, Division of Hematology-Oncology, Tufts Medical Center, Boston, MA 02111, USA. rbuchsbaum@tuftsmedicalcenter.org.
authors.forename: Rachel J
authors.initials: RJ
authors.lastname: Buchsbaum
authors.affiliation: Department of Medicine, Division of Medical Oncology, Montefiore Medical Center, New York, NY 10467, USA. suyoung@montefiore.org.
authors.forename: Sun Young
authors.initials: SY
authors.lastname: Oh
keywords: breast cancer; cancer-associated fibroblasts; tumor microenvironment
references.citation: J Pathol. 2008 Feb;214(3):357-67
references.pmid: 18044827
references.citation: Br J Cancer. 2008 Nov 4;99(9):1375-9
references.pmid: 18797460
references.citation: Nat Med. 2008 May;14(5):518-27
references.pmid: 18438415
references.citation: Nat Rev Mol Cell Biol. 2002 May;3(5):349-63
references.pmid: 11988769
references.citation: J Clin Oncol. 2004 Aug 1;22(15):3080-90
references.pmid: 15284258
references.citation: Cancer Res. 2004 Jan 15;64(2):612-21
references.pmid: 14744776
references.citation: Crit Rev Oncol Hematol. 2005 Jan;53(1):35-69
references.pmid: 15607934
references.citation: Oncotarget. 2015 Mar 30;6(9):6472-98
references.pmid: 25762624
references.citation: Nat Med. 2013 Nov;19(11):1423-37
references.pmid: 24202395
references.citation: Cancer Res. 2012 Mar 15;72(6):1416-27
references.pmid: 22282662
references.citation: J Pathol. 2004 Nov;204(4):386-95
references.pmid: 15495226
references.citation: Cancer Res. 2001 Feb 15;61(4):1320-6
references.pmid: 11245428
references.citation: Nat Genet. 2005 Aug;37(8):899-905
references.pmid: 16007089
references.citation: Endocr Relat Cancer. 2013 Jan 07;20(1):1-12
references.pmid: 23111755
references.citation: Oncogene. 2015 Sep 10;34(37):4821-33
references.pmid: 25531323
references.citation: Breast Cancer Res Treat. 1988 May;11(2):165-72
references.pmid: 3042052
references.citation: Cancer Biol Ther. 2011 Nov 15;12(10):924-38
references.pmid: 22041887
references.citation: J Biol Chem. 2002 Feb 15;277(7):4589-92
references.pmid: 11717317
references.citation: Endocr Relat Cancer. 2006 Dec;13(4):1085-99
references.pmid: 17158755
references.citation: Breast Cancer Res Treat. 2012 Jun;133(2):459-71
references.pmid: 21935603
references.citation: Dev Dyn. 2005 Jul;233(3):706-20
references.pmid: 15937929
references.citation: Matrix Biol. 2014 Jul;37:131-41
references.pmid: 24657887
references.citation: Clin Exp Metastasis. 2011 Apr;28(4):351-66
references.pmid: 21374085
references.citation: Tumour Biol. 2004 Sep-Dec;25(5-6):290-5
references.pmid: 15627894
references.citation: Thromb Haemost. 2003 Feb;89(2):393-404
references.pmid: 12574821
references.citation: J Clin Oncol. 2009 Mar 10;27(8):1160-7
references.pmid: 19204204
references.citation: BMC Cancer. 2014 Dec 15;14:955
references.pmid: 25512109
references.citation: Crit Rev Oncol Hematol. 2015 Apr;94(1):1-17
references.pmid: 25563413
references.citation: Cell. 2011 Oct 14;147(2):275-92
references.pmid: 22000009
references.citation: Antioxid Redox Signal. 2012 Jun 1;16(11):1264-84
references.pmid: 21883043
references.citation: Breast Cancer Res. 2012 Jul 12;14(4):R104
references.pmid: 22788954
references.citation: Endocr Relat Cancer. 2014 Mar 07;21(2):355-69
references.pmid: 24481325
references.citation: Blood. 2003 Jan 1;101(1):168-72
references.pmid: 12393704
references.citation: Cancer Res. 2008 Jun 1;68(11):4331-9
references.pmid: 18519693
references.citation: Oncogene. 2010 Mar 25;29(12):1732-40
references.pmid: 20062080
references.citation: Pathophysiology. 2010 Sep;17(4):229-51
references.pmid: 20036110
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16472-7
references.pmid: 17060621
references.citation: Am J Pathol. 2008 Jan;172(1):179-93
references.pmid: 18079437
references.citation: Oncogene. 2010 Dec 16;29(50):6533-42
references.pmid: 20802514
references.citation: Cancer Biol Ther. 2011 Feb 15;11(4):383-94
references.pmid: 21150282
references.citation: Cancer Res. 2006 Jan 1;66(1):29-33
references.pmid: 16397211
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4966-71
references.pmid: 15051869
references.citation: Cell. 2014 Jul 31;158(3):564-78
references.pmid: 25083868
references.citation: Nat Rev Cancer. 2006 May;6(5):392-401
references.pmid: 16572188
references.citation: Anticancer Res. 2013 Apr;33(4):1447-55
references.pmid: 23564785
references.citation: J Mammary Gland Biol Neoplasia. 2014 Jul;19(2):169-82
references.pmid: 24984900
references.citation: Cancer Microenviron. 2012 Apr;5(1):83-93
references.pmid: 22314376
references.citation: Am J Pathol. 2009 Jun;174(6):2035-43
references.pmid: 19411449
references.citation: Cancer Cell. 2010 Feb 17;17(2):135-47
references.pmid: 20138012
references.citation: Breast Cancer Res Treat. 2008 Jul;110(2):273-81
references.pmid: 17899370
references.citation: Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12072-7
references.pmid: 11593017
references.citation: BMC Med Genomics. 2012 Sep 06;5:39
references.pmid: 22954256
references.citation: Cancer Res. 2007 Nov 1;67(21):10123-8
references.pmid: 17974953
references.citation: Exp Cell Res. 1965 Mar;37:614-36
references.pmid: 14315085
references.citation: Biosci Rep. 2013 Dec 12;33(6):null
references.pmid: 24229053
references.citation: Virchows Arch. 2014 Sep;465(3):291-8
references.pmid: 24980157
references.citation: J Clin Oncol. 2008 May 20;26(15):2568-81
references.pmid: 18487574
references.citation: Cancer Metastasis Rev. 2013 Jun;32(1-2):303-15
references.pmid: 23114846
references.citation: Cell. 2008 May 16;133(4):704-15
references.pmid: 18485877
references.citation: Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20009-14
references.pmid: 21041659
references.citation: Med Oncol. 2014 Sep;31(9):24
references.pmid: 25142945
references.citation: Nat Med. 2001 Feb;7(2):192-8
references.pmid: 11175850
references.citation: Br J Cancer. 2014 Feb 4;110(3):724-32
references.pmid: 24335925
references.citation: Int J Cancer. 1988 May 15;41(5):707-12
references.pmid: 2835323
references.citation: Cell. 2013 Aug 29;154(5):1060-73
references.pmid: 23993096
references.citation: Adv Cancer Res. 2007;97:247-74
references.pmid: 17419949
references.citation: Appl Immunohistochem Mol Morphol. 2014 Jan;22(1):10-6
references.pmid: 23455186
references.citation: Immunobiology. 2010 Sep-Oct;215(9-10):737-47
references.pmid: 20605053
references.citation: Int J Cancer. 2001 Jan 20;95(1):67-72
references.pmid: 11241314
references.citation: PLoS One. 2009 Nov 23;4(11):e7965
references.pmid: 19956757
references.citation: Cancer Res. 2015 Mar 15;75(6):963-73
references.pmid: 25600648
references.citation: BMC Med. 2010 May 21;8:27
references.pmid: 20492690
references.citation: J Exp Med. 2015 Dec 14;212(13):2253-66
references.pmid: 26621452
references.citation: Cancer Res. 2012 Sep 15;72(18):4652-61
references.pmid: 22826604
references.citation: Am J Pathol. 2009 Jun;174(6):2023-34
references.pmid: 19411448
references.citation: Breast Cancer Res. 2009;11(1):R3
references.pmid: 19152687
references.citation: Anticancer Res. 2013 Apr;33(4):1525-36
references.pmid: 23564794
references.citation: FASEB J. 1992 Apr;6(7):2397-404
references.pmid: 1563592
references.citation: Pathol Oncol Res. 2012 Apr;18(2):459-69
references.pmid: 22057638
references.citation: N Engl J Med. 1986 Dec 25;315(26):1650-9
references.pmid: 3537791
references.citation: J Surg Oncol. 1998 Jun;68(2):107-12
references.pmid: 9624040
references.citation: Cancer Biol Ther. 2004 Oct;3(10):931-41
references.pmid: 15539932
references.citation: Cancer Lett. 2015 Jun 1;361(2):155-63
references.pmid: 25700776
references.citation: Cell Cycle. 2012 Aug 15;11(16):3019-35
references.pmid: 22874531
references.citation: J Clin Oncol. 2005 Oct 10;23(29):7350-60
references.pmid: 16145060
references.citation: Cancer Cell. 2008 May;13(5):394-406
references.pmid: 18455123
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3372-7
references.pmid: 19218449
references.citation: Cell Cycle. 2010 Aug 15;9(16):3256-76
references.pmid: 20814239
references.citation: J Cell Sci. 2012 Jan 15;125(Pt 2):376-86
references.pmid: 22302986
references.citation: Am J Pathol. 2009 Jul;175(1):334-41
references.pmid: 19498003
references.citation: Anticancer Res. 2007 Jul-Aug;27(4C):2917-24
references.pmid: 17695471
references.citation: J Clin Oncol. 2005 Aug 10;23(23):5323-33
references.pmid: 15939921
references.citation: J Clin Invest. 1995 Feb;95(2):859-73
references.pmid: 7532191
references.citation: Eur J Cancer. 2002 Dec;38(18):2362-70
references.pmid: 12460779
references.citation: J Steroid Biochem Mol Biol. 2013 Jan;133:12-24
references.pmid: 22939885
references.citation: J Natl Cancer Inst. 2009 May 20;101(10):736-50
references.pmid: 19436038
references.citation: Neoplasia. 2013 Mar;15(3):249-62
references.pmid: 23479504
references.citation: Breast Cancer Res. 2005;7(1):R46-59
references.pmid: 15642169
references.citation: Am J Pathol. 2007 May;170(5):1546-60
references.pmid: 17456761
references.citation: Prostate. 2003 Apr 1;55(1):30-8
references.pmid: 12640658
references.citation: Int J Biochem Cell Biol. 2002 Nov;34(11):1401-14
references.pmid: 12200035
references.citation: PLoS One. 2012;7(4):e35128
references.pmid: 22514714
references.citation: J Endocrinol. 2003 Apr;177(1):65-81
references.pmid: 12697038
references.citation: J Biol Chem. 2008 Apr 18;283(16):10892-903
references.pmid: 18281291
references.citation: Breast Cancer. 2012 Apr;19(2):170-6
references.pmid: 20978953
references.citation: Oncogene. 2006 Mar 2;25(9):1408-12
references.pmid: 16247452
references.citation: Arch Iran Med. 2013 Feb;16(2):93-9
references.pmid: 23360631
references.citation: Int J Oncol. 2011 Sep;39(3):689-96
references.pmid: 21667024
references.citation: Int J Cancer. 2014 Nov 1;135(9):2024-33
references.pmid: 24643985
references.citation: Cell Death Differ. 2016 Jan;23(1):132-45
references.pmid: 26068592
references.citation: J Clin Oncol. 2010 Apr 1;28(10):1684-91
references.pmid: 20194857
references.citation: Histopathology. 2011 Dec;59(6):1249-60
references.pmid: 22175904
references.citation: Cancer Biol Ther. 2008 Aug;7(8):1212-25
references.pmid: 18458534
references.citation: Nat Rev Cancer. 2003 Jun;3(6):453-8
references.pmid: 12778135
references.citation: Curr Opin Cell Biol. 2003 Dec;15(6):740-6
references.pmid: 14644200
references.citation: Biochim Biophys Acta. 2004 Mar 4;1654(1):3-12
references.pmid: 14984763
references.citation: Cell Cycle. 2009 Dec;8(23):3984-4001
references.pmid: 19923890
references.citation: Cancer Biol Ther. 2010 Jul 15;10(2):135-43
references.pmid: 20431349
references.citation: Ann Oncol. 2013 Jan;24(1):126-33
references.pmid: 22865780
references.citation: Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21677-82
references.pmid: 21098274
references.citation: Cancer Biol Ther. 2006 Dec;5(12):1640-6
references.pmid: 17106243
references.citation: Cell Death Differ. 2005 Nov;12 Suppl 2:1509-18
references.pmid: 16247498
references.citation: J Cell Sci. 2010 Oct 15;123(Pt 20):3507-14
references.pmid: 20841377
references.citation: Mol Cell Biol. 1992 Mar;12(3):954-61
references.pmid: 1312220
references.citation: Am J Pathol. 1999 Feb;154(2):385-94
references.pmid: 10027397
references.citation: Vasc Health Risk Manag. 2006;2(3):213-9
references.pmid: 17326328
references.citation: Cell. 2005 May 6;121(3):335-48
references.pmid: 15882617
references.citation: Breast Cancer Res Treat. 2012 Jul;134(1):237-44
references.pmid: 22350732
references.citation: Cell Cycle. 2010 Jun 1;9(11):2201-19
references.pmid: 20519932
references.citation: Nat Rev Cancer. 2011 Sep 23;11(10):735-48
references.pmid: 21941285
references.citation: Clin Cancer Res. 1995 Sep;1(9):1035-41
references.pmid: 9816077